| http://www.w3.org/ns/prov#value | - I felt every project wasn't using all the information available to it, and one of the kinds of information left out most often was the structural information, telling you what a drug was supposed to do, says Dr. Boger, now a board member at Vertex, based in Cambridge, Mass., whose hepatitis C therapy, Incivek, was approved last year.
|